CES1 and CES2 are the two major liver carboxylesterases which belong to the type-B carboxylesterase/lipase family. Helping the body in the detoxification of a wide range of xenobiotics, CES1 and CES2 are involved in the hydrolyzing activation of therapeutic ester and amide pro-drugs, as well as in the detoxification of several narcotic compounds. The catalytic activity of CES1 and CES2 is influenced by both the esterification site and the structure/moiety of the amino acid. While CES1 shows high affinity for aromatic and aliphatic esters, CES2 shows high affinity for 3,6-diacetyl and 6-monoacetly esters, such as those found in morphine and morphine derivatives. Since CES1 and CES2 are crucial in the breakdown of various foreign molecules, several therapeutic compounds, such as anti-tumor agents, are structurally designed to target the catalytic sites of one or both of these key carboxylesterase proteins.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of CES1 of rat origin by WB, IP, IF and ELISA
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 351-390 mapping within an internal region of CES1 of rat origin
Tissue Specificity
epitope corresponding to amino acids 351-390 mapping within an internal region of CES1 of rat origin
Application
Application
Western blot analysis of CES1 expression in rat PBL whole cell lysate (A) and rat adrenal gland (B) and rat liver (C) tissue extracts.
Application Notes
recommended for detection of CES1 of rat origin by WB, IP, IF and ELISA
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.